Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Risk of severe adverse outcomes associated with VEGFR-TKIs treatment compared with placebo treatment: (A) FAEs, (B) any severe adverse events, and (C) treatment discontinuation.
Notes: Group A: VEGFR-TKIs group; Group-B: placebo group.
Abbreviations: CI, confidence interval; FAEs, fatal adverse events; VEGFR-TKIs, vascular endothelial growth factor receptor tyrosine kinase inhibitors.
